New Boron Containing Acridines: Synthesis and Preliminary Biological Study.
Anna A DruzinaNadezhda V DudarovaIvan V AnanyevAnastasia A AntonetsDmitry N KaluzhnyAlexey A NazarovIgor B SivaevVladimir I BregadzePublished in: Molecules (Basel, Switzerland) (2023)
The synthesis of the first conjugates of acridine with cobalt bis(dicarbollide) are reported. A novel 9-azido derivative of acridine was prepared through the reaction of 9-methoxyacridine with N 3 CH 2 CH 2 NH 2 , and its solid-state molecular structure was determined via single-crystal X-ray diffraction. The azidoacridine was used in a copper (I)-catalyzed azide-alkyne cycloaddition reaction with cobalt bis(dicarbollide)-based terminal alkynes to give the target 1,2,3-triazoles. DNA interaction studies via absorbance spectroscopy showed the weak binding of the obtained conjugates with DNA. The antiproliferative activity (IC 50 ) of the boronated conjugates against a series of human cell lines was evaluated through an MTT assay. The results suggested that acridine derivatives of cobalt bis(dicarbollide) might serve as a novel scaffold for the future development of new agents for boron neutron capture therapy (BNCT).
Keyphrases
- solid state
- room temperature
- ionic liquid
- single molecule
- circulating tumor
- reduced graphene oxide
- cancer therapy
- cell free
- endothelial cells
- metal organic framework
- high resolution
- carbon nanotubes
- current status
- induced pluripotent stem cells
- stem cells
- magnetic resonance
- pluripotent stem cells
- mass spectrometry
- drug delivery
- smoking cessation
- cell therapy